FeedsPrimary Location:University of Alabama at BirminghamBone Marrow Transplant & Cell Therapy Program619 South 19th Street P302 West Pavilion Birmingham, AL 35249-6979 Direct phone: (205) 996-2268 http://www.bonemarrow.uab.edu | Secondary Location:The Children's Hospital of AlabamaLowder Stem Cell Transplant Unit1600 7th Avenue South Birmingham, AL 35233 Direct phone: (205) 939-6721 http://sc.chsys.org |
Program Description: |
The "single-staff model" UAB BMT Program provides all inpatient and outpatient care on a 24 hour, 7 day schedule in specially designed units at University and Children's Hospitals for adults and children receiving the entire range of blood and marrow transplants. |
||||||||||
Contact Information: |
If you have transplant-related questions, please contact Diana Tate, transplant center coordinator, at (205) 934-1911 or by e-mail at dftate@uabmc.edu. |
||||||||||
Program Type: |
Adult (ages 14 to 75) and Pediatric (ages 1 to 19) |
||||||||||
Attending Physicians:(Medical Doctors) |
Adult -Raquel Innis-Shelton, Richard Lopez, Donna Salzman, William VaughanPediatric -Joseph Chewning, Frederick Goldman, Sandhya Kharbanda |
||||||||||
Transplants Performed: |
Marrow/PBSC, single cord, and double cord |
||||||||||
Cord blood transplants performed on: |
Pediatric only |
||||||||||
Mismatches allowed:For marrow, PBSC, or cord blood transplant with an unrelated donor. Match criteria may vary based on patient's age, disease type and stage. |
|
||||||||||
Explain Transplant Center HLA Match Requirements
Estimated Search & Transplant Costs |
|
| Costs vary greatly from center to center, and depend on factors such as health insurance, disease type, and disease stage of the patient, as well as center-specific billing policies. | |
| Activation of formal search | $1,900 - 2,397 |
| DR testing of A/B tested donors (per donor) | $1,168 |
| Confirmatory typing blood sample (per sample) | $2,150 - 5,103 |
| IDM sample collection/testing (per donor) | $980 - 1,159 |
| High resolution - HLA typing | $612 - 5,103 |
| Marrow or PBSC procurement | $47,498 |
| Cord blood procurement (including shipping fees) | $49,314 |
| Cord blood typing | N/A |
|
The costs listed above are only a small part of the total cost of a transplant. Contact your transplant center to learn more about costs of actual transplant and follow-up treatment. |
|
Explain Transplant Costs at Different Centers
Financial Services:Financial services at this center could include:
|
Resources for financial informationIf you have questions about costs and financial services at this transplant center, you can contact the center's financial representative, Syzmanski Fields at (205) 975-5713 or by e-mail at sfields@uabmc.edu. Many organizations exist to help patients with lodging, transportation and other transplant-related expenses. Visit the National Marrow Donor Program's Patient Organizations database for more information. Financial assistance resources are also listed on this Web site. |
Transplant Experience |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This center has been performing allogeneic transplants since
1992 and has been an NMDP transplant center since November 1995.
This center performed a total of 100 transplants, all types, in the most recent year (from June 2008 to May 2009) *The total Non-Myeloblative transplants column shows a subset of the total number of transplants by type. To locate centers that perform cord blood transplants, use the search tool on this site. The NMDP also has Transplants by Disease Charts available showing the number of NMDP coordinated transplants by disease category at each U.S. transplant center. Center-Specific Analysis (Using unrelated NMDP donors)This analysis is based on transplants performed from Jan. 1, 2003 through Dec. 31, 2007, using unrelated NMDP donors. It only includes patients who were confirmed to be either alive or deceased within one year of transplant.
For help with understanding these statistics, please see How to Understand NMDP Transplant Center Statistics. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Survival by Patient's Age, Disease Type and Stage (Using unrelated NMDP donors)
This data is only based on unrelated transplants performed from Jan. 2003 to Dec. 2007. It also includes one year post-transplant follow-up, through Dec. 2008. The first number represents the number of patients alive at one year post transplant. The second number is a total number of transplanted patients in that particular group.
| CP = chronic phase (1st or 2nd) | BP = blastic phase |
| AP = accelerated phase | CR = complete remission (1st, 2nd, 3rd or more) |
| RLPS = relapse | PIF = primary induction failure |
Diagnoses |
0-10 |
11-17 |
18-30 |
31-40 |
41-50 |
51-60 |
> 60 |
Overall |
| Acute Lymphoblastic Leukemia | -- | -- | 0/1 | -- | -- | -- | -- | 0/1 |
| Acute Lymphoblastic Leukemia 1CR | 1/1 | 2/2 | -- | -- | 0/1 | 0/1 | -- | 3/5 |
| Acute Lymphoblastic Leukemia 2CR | 3/3 | 1/2 | 1/2 | -- | -- | -- | -- | 5/7 |
| Acute Myelogenous Leukemia 1CR | 0/1 | -- | 0/1 | 2/3 | 1/1 | -- | -- | 3/6 |
| Acute Myelogenous Leukemia 2CR | 2/3 | -- | -- | -- | 0/2 | 1/1 | -- | 3/6 |
| Acute Myelogenous Leukemia 3+CR/RLPS | -- | 1/1 | -- | -- | -- | -- | -- | 1/1 |
| Acute Myelogenous Leukemia PIF | 0/1 | -- | -- | -- | -- | -- | -- | 0/1 |
| Chronic Lymphocytic Leukemia | -- | -- | -- | -- | 1/2 | -- | -- | 1/2 |
| Chronic Myelogenous Leukemia 1CP | -- | 2/2 | 1/1 | 0/1 | -- | -- | -- | 3/4 |
| Chronic Myelogenous Leukemia 2CP | -- | -- | 0/1 | 0/1 | 1/1 | -- | -- | 1/3 |
| Chronic Myelogenous Leukemia AP | -- | -- | -- | -- | -- | 0/1 | -- | 0/1 |
| Combined Immunodeficiency | 1/1 | -- | -- | -- | -- | -- | -- | 1/1 |
| Familial Erythrophagocytic Lymphohistiocytosis | 0/1 | -- | -- | -- | -- | -- | -- | 0/1 |
| Fanconi Anemia | 1/1 | -- | -- | -- | -- | -- | -- | 1/1 |
| MDS-Other Myelodysplastic Disorder | -- | -- | -- | 0/1 | 0/1 | -- | 1/1 | 1/3 |
| MDS-Refractory Anemia-Excess Blasts | -- | -- | 1/1 | -- | -- | 1/1 | -- | 2/2 |
| MDS-Unknown Myelodysplastic Disorder | -- | -- | -- | 1/2 | -- | 1/1 | -- | 2/3 |
| Multiple Myeloma | -- | -- | -- | 0/1 | -- | -- | -- | 0/1 |
| Myelofibro Myeloid Metaplasia | -- | -- | -- | 0/1 | 1/1 | -- | -- | 1/2 |
| Neutrophil Defect (Chediak-Higashi Syndrome) | 1/1 | -- | -- | -- | -- | -- | -- | 1/1 |
| Non-Hodgkin's Lymphoma | -- | -- | -- | 0/1 | 0/1 | 1/1 | -- | 1/3 |
| Other Acute Leukemia | 1/1 | -- | -- | -- | 1/1 | -- | -- | 2/2 |
| Other Immune System Disorder | 1/1 | -- | -- | -- | -- | -- | -- | 1/1 |
| Other Non-Malignant Disease | -- | 1/1 | -- | -- | -- | -- | -- | 1/1 |
| SCID - Absence of T, Normal B | 3/3 | -- | -- | -- | -- | -- | -- | 3/3 |
| SCID - Other | 2/2 | -- | -- | -- | -- | -- | -- | 2/2 |
| Severe Aplastic Anemia | 1/1 | -- | 1/1 | 2/2 | -- | -- | -- | 4/4 |
| Wiskott-Aldrich Syndrome | 1/1 | -- | -- | -- | -- | -- | -- | 1/1 |
| Total | 18/22 | 7/8 | 4/8 | 5/13 | 5/11 | 4/6 | 1/1 | 44/69 |
Explain Survival by Patient Diagnosis and Age
BMT InfoNet (Blood & Marrow Transplant Information Network) is a nonprofit organization that provides information and emotional support to transplant patients and their families.
